Pancreatic Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Pancreatic Cancer Diagnostic Tests include assays of mostly antibodies released in response to a pancreatic cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Pancreatic Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Pancreatic Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to:
Extensive coverage of the Pancreatic Cancer Diagnostic Tests under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Pancreatic Cancer Diagnostic Tests pipeline products.
Review of Recent Developments in the segment / industry
The Pancreatic Cancer Diagnostic Tests Pipeline Assessment report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Pancreatic Cancer Diagnostic Tests under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
The major companies covered in the “Pancreatic Cancer Diagnostic Tests- Medical Devices Pipeline Assessment, 2020” report:
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.
Scope
– Extensive coverage of the Pancreatic Cancer Diagnostic Tests under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Pancreatic Cancer Diagnostic Tests and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Pancreatic Cancer Diagnostic Tests under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
3rd Street Diagnostics
A&G Pharmaceutical Inc
Abcodia Ltd
Acobiom
Advanced Marker Discovery SL
Alaunus Biosciences Inc
Amplified Sciences LLC
Anixa Diagnostics Corporation
Applied Proteomics Inc
Avant Diagnostics Inc
Axim Biotechnologies Inc
Berg LLC
BioMarker Strategies LLC
BiomaRx Inc
Bioprognos SL
Biouniversa srl
Cancer Research Technology Ltd
Captis Biotechnology Inc
Caris Life Sciences Inc
Cepheid Inc
Clovis Oncology Inc
Courtagen Life Sciences Inc
CS-Keys
Inc. (Inactive)
Di.V.A.L Toscana srl
Exact Sciences Corp
Fred Hutchinson Cancer Research Center
Fujirebio Diagnostics Inc
GlycoZym USA Inc
Health Discovery Corp
Houston Methodist Hospital
ImmunoCellular Therapeutics Ltd
Immunomedics Inc
Immunovia AB
Johns Hopkins University
JW Bioscience
Leitat Technological Center
Matrix-Bio Inc
MDNA Life Sciences Inc
Memorial Sloan Kettering Cancer Center
Merrimack Pharmaceuticals Inc
Metanomics Health GmbH
Milagen Inc
Myriad Genetics Inc
NanoScale Corp
Nanoview Biosciences Inc
NatiMab Therapeutics Srl
National Cheng-Kung University Hospital
Oncimmune (USA) LLC
Oncomatryx Biopharma SL
Onconome
Inc. (Inactive)
OPKO Health Inc
OTraces Inc
Oxford Gene Technology Ltd
Penn Medicine
Peri Rx Inc
Precision Biologics Inc
Preora Healthcare Inc
Proplex Technologies Llc
Protagen AG
Proteome Sciences Plc
Quanterix Corp
Reccan Diagnostics AB
RISE Life Science Corp
Rutgers The State University of New Jersey
Sanguine Diagnostics and Therapeutics Inc
SDIX LLC
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Sienna Cancer Diagnostics Ltd
SomaLogic Inc
Stanford University
Taizhou ZECEN Biotech Co Ltd
Temple University Health System
Thomas Jefferson University
University of California San Francisco
University of Illinois at Chicago
University of Liverpool
University of Pennsylvania
University of Texas MD Anderson Cancer Center
University of Washington
US Biomarkers Inc
Vajra Instruments Inc
Vastcon Inc
Ventana Medical Systems Inc
Viomics Inc.
VolitionRX Ltd
ZORA Biosciences Oy
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Pancreatic Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
